No-touch disinfection methods to decrease multidrug-resistant organism infections: A systematic review and meta-analysis

Infection Control and Hospital Epidemiology

Volumn 39, Issue 1, 2018, Pages 20-31

  Marra, Alexandre R ^a,b   Schweizer, Marin L ^c,d,e   Edmond, Michael B ^a,e  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c UNIVERSITY OF IOWA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISINFECTION; HOSPITAL INFECTION; INFECTION RATE; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; ORGANISMS; PEPTOCLOSTRIDIUM DIFFICILE; SYSTEMATIC REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIAL INFECTION; CLOSTRIDIUM INFECTION; CROSS INFECTION; DRUG EFFECT; HUMAN; INFECTION CONTROL; MICROBIOLOGY; PROCEDURES; ULTRAVIOLET RADIATION;

HYDROGEN PEROXIDE;

BACTERIAL INFECTIONS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DISINFECTION; HUMANS; HYDROGEN PEROXIDE; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; ULTRAVIOLET RAYS; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 85034595795     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2017.226     Document Type: Article

References (47)

1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllisterHollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK. Emerging Infections Program HealthcareAssociated Infections, and Antimicrobial Use Prevalence Survey Team. Multistate pointprevalence survey of health careassociated infections. N Engl J Med 2014; 370: 1198-1208.
2. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, Keohane C, Denham CR, Bates DW. Health careassociated infections: a metaanalysis of costs, and financial impact on the US health care system. JAMA Intern Med 2013; 173: 2039-2046.
3. Huang SS, Datta R, Platt R. Risk of acquiring antibioticresistant bacteria from prior room occupants. Arch Intern Med 2006; 166: 1945-1951.
4. Weber DJ, Rutala WA, Miller MB, Huslage K, SickbertBennett E. Role of hospital surfaces in the transmission of emerging healthcareassociated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 2010; 38: S25-S33.
5. Shaughnessy MK, Micielli RL, DePestel DD, Arndt J, Strachan CL, Welch KB, Chenoweth CE. Evaluation of hospital room assignment, and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011; 32: 201-206.
6. Mitchell BG, Dancer SJ, Anderson M, Dehn E. Risk of organism acquisition from prior room occupants: a systematic review, and metaanalysis. J Hosp Infect 2015; 91: 211-217.
7. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006; 6: 130.
8. Dancer SJ. Controlling hospitalacquired infection: focus on the role of the environment, and new technologies for decontamination. Clin Microbiol Rev 2014; 27: 665-690.
9. Wenzel RP, Edmond MB. Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis 2010; 14(S1): S3-S5.
10. Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcareassociated infections. Curr Opin Infect Dis 2013; 26: 338-344.
11. Carling PC, Parry MF, BrunoMurtha LA, Dick B. Improving environmental hygiene in 27 intensive care units to decrease multidrugresistant bacterial transmission. Crit Care Med 2010; 38: 1054-1059.
12. Leas BF, Sullivan N, Han JH, Pegues DA, Kaczmarek JL, Umscheid CA. Environmental cleaning for the prevention of healthcareassociated infections. Rockville, MD: Agency for Healthcare Research, and Quality (US); 2015 Aug. Report no.: 15 EHC020EF.
13. Boyce JM. Modern technologies for improving cleaning, and disinfection of environmental surfaces in hospitals. Antimicrob Resist Infect Control 2016; 5: 10.
14. Doll M, Morgan DJ, Anderson D, Bearman G. Touchless technologies for decontamination in the hospital: a review of hydrogen peroxide, and UV devices. Curr Infect Dis Rep 2015; 17: 44.
15. Weber DJ, Rutala WA, Anderson DJ, Chen LF, SickbertBennett EE, Boyce JM. Effectiveness of ultraviolet devices, and hydrogen peroxide systems for terminal room decontamination: focus on clinical trials. Am J Infect Control 2016; 44(5 Suppl): e77-e84.
16. Weber DJ, Kanamori H, Rutala WA. No touch technologies for environmental decontamination: focus on ultraviolet devices, and hydrogen peroxide systems. Curr Opin Infect Dis 2016; 29: 424-431.
17. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews, and metaanalyses: The PRISMA statement. Plos Med 2009; 6: e1000097.
18. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Metaanalysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis of observational studies in epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
19. Aboelela SW, Saiman L, Stone P, Lowy FD, Quiros D, Larson E. Effectiveness of barrier precautions, and surveillance cultures to control transmission of multidrugresistant organisms: a systematic review of the literature. Am J Infect Control 2006; 34: 484-494.
20. Cohen CC, Cohen B, Shang J. Effectiveness of contact precautions against multidrugresistant organism transmission in acute care: a systematic review of the literature. J Hosp Infect 2015; 90: 275-284.
21. Alderson PGS, Higgins JPT. editors Assessment of study quality. Cochrane reviewer?s handbook 4.2.3 [Updated November 2004]. Chichester, UK: John Wiley & Sons; 2004.
22. Harris AD, Lautenbach E, Perencevich E. A systematic review of quasiexperimental study designs in the fields of infection control, and antibiotic resistance. Clin Infect Dis 2005; 41: 77-82.
23. Boyce JM, Havill NL, Otter JA, McDonald LC, Adams NM, Cooper T, Thompson A, Wiggs L, Killgore G, Tauman A, Noble Wang J. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination, and transmission in a healthcare setting. Infect Control Hosp Epidemiol 2008; 29: 723-729.
24. Catalanotti A, Abbe D, Simmons S, Stibich M. Influence of pulsedxenon ultraviolet lightbased environmental disinfection on surgical site infections. Am J Infect Control 2016; 44: e99-e101.
25. Cooper T, O? Leary, Yezli S, Otter JA. Impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital Trust. J Hosp Infect 2011; 78: 238-240.
26. Green C, Pamplin JC, Chafin KN, Murray CK, Yun HC. Pulsedxenon ultraviolet light disinfection in a burn unit: Impact on environmental bioburden, multidrug resistant organism acquisition, and healthcare associated infections. Burns 2017; 43: 388-396.
27. Horn K, Otter JA. Hydrogen peroxide vapor room disinfection, and hand hygiene improvements reduce Clostridium difficile infection, methicillinresistant Staphylococcus aureus, vancomycinresistant enterococci, and extendedspectrum βlactamase. Am J Infect Control 2015; 43: 1354-1356.
28. Levin J, Riley LS, Parrish C, English D, Ahn S. The effect of portable pulsed xenon ultraviolet light after terminal cleaning on hospitalassociated Clostridium difficile infection in a community hospital. Am J Infect Control 2013; 41: 746-748.
29. Manian FA, Griesnauer S, Bryant A. Implementation of hospitalwide enhanced terminal cleaning of targeted patient rooms, and its impact on endemic Clostridium difficile infection rates. Am J Infect Control 2013; 41: 537-541.
30. McCord J, Prewitt M, Dyakova E, Mookerjee S, Otter JA. Reduction in Clostridium difficile infection associated with the introduction of hydrogen peroxide vapour automated room disinfection. J Hosp Infect 2016; 94: 185-187.
31. Bernard H, Little J. The impact of ultraviolet (UV) disinfection system coupled with evidencebased interventions on the incidence of hospital onset Clostridium difficile (HOCDiff). Am J Infect Control 2015; 43: S27.
32. Miller R, Simmons S, Dale C, Stachowiak J, Stibich M. Utilization, and impact of a pulsedxenon ultraviolet room disinfection system, and multidisciplinary care team on Clostridium difficile in a longterm acute care facility. Am J Infect Control 2015; 43: 1350-1353.
33. Mitchell BG, Digney W, Locket P, Dancer SJ. Controlling methicillinresistant Staphylococcus aureus (MRSA) in a hospital, and the role of hydrogen peroxide decontamination: an interrupted time series analysis. BMJ Open 2014; 4: e004522.
34. Pegues DA, Han J, Gilmar C, McDonnell B, Gaynes S. Impact of ultraviolet germicidal irradiation for notouch terminal room disinfection on Clostridium difficile infection incidence among hematologyoncology patients. Infect Control Hosp Epidemiol 2017; 38: 39-44.
35. Vianna PG, Dale CR Jr, Simmons S, Stibich M, Licitra CM. Impact of pulsed xenon ultraviolet light on hospitalacquired infection rates in a community hospital. Am J Infect Control 2016; 44: 299-303.
36. Haas JP, Menz J, Dusza S, Montecalvo MA. Implementation, and impact of ultraviolet environmental disinfection in acute care setting. Am J Infect Control 2014; 42: 586-590.
37. Napolitano NA, Mahapatra T, Tang W. The effectiveness of UVC radiation for facilitywide environmental disinfection to reduce healthcareacquired infections. Am J Infect Control 2015; 43: 1342-1346.
38. Nagaraja A, Visintainer P, Haas JP, Menz J, Wormser GP, Montecalvo MA. Clostridium difficile infections before, and during use of ultraviolet disinfection. Am J Infect Control 2015; 43: 940-945.
39. McMullen K, Wood H, Buol W, Johnson D, Bradley A, Dubberke E, Woeltje K, Warren D. Impact of a pulsed xenon ultraviolet light (PXUV) light room disinfection system on Clostridium difficile infection rates. Infectious Diseases Society of America website. https://idsa.confex.com/idsa/2015/webprogram/Handout/POSTER240-1714.pdf. Published 2015. Accessed October 16, 2017.
40. Passaretti CL, Otter JA, Reich NG, Myers J, Shepard J, Ross T, Carroll KC, Lipsett P, Perl TM. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrugresistant organisms. Clin Infect Dis 2013; 56: 27-35.
41. Anderson DJ, Chen LF, Weber DJ, Moehring RW, Lewis SS, Triplett PF, Blocker M, Becherer P, Schwab JC, Knelson LP, Lokhnygina Y, Rutala WA, Kanamori H, Gergen MF, Sexton DJ, CDC Prevention Epicenters Program. Enhanced terminal room disinfection, and acquisition, and infection caused by multidrug resistant organisms, and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a clusterrandomised, multicentre, crossover study. Lancet 2017; 389: 805-814.
42. Sampathkumar P, Nation L, Folkert C, Wentink JE, Zavaleta KW. A trial of pulsed xenon ultraviolet disinfection to reduce C. difficile infection. Am J Infect Control 2016; 44: S30-S31.
43. Weber DJ, Rutala WA. The role of environment in transmission of Clostridium difficile infection in healthcare facilities. Infect Control Hosp Epidemiol 2011; 32: 207-209.
44. Shams AM, Rose LJ, Edwards JR, Cali S, Harris AD, Jacob JT, LaFae A, Pineles LL, Thom KA, McDonald LC, Arduino MJ, NobleWang JA. Assessment of the overall, and multidrugresistant organism bioburden on environmental surfaces in healthcare facilities. Infect Control Hosp Epidemiol 2016; 37: 1426-1432.
45. Carling PC, Parry MF, Von Boheren SM, Healthcare Environmental Hygiene Study Group. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol 2008; 29: 1-7.
46. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012; 55(Suppl): S88-S92.
47. Cosgrove SE. The relationship between antimicrobial resistance, and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006; 42(Suppl): S82-S89.